We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Rapid New Test Developed for MRSA

By HospiMedica staff writers
Posted on 09 Feb 2006
A new screening method for methicillin-resistant Staphylococcus aureus (MRSA) slashes the time needed to identify patients with MRSA by 75%, decreasing the time between screening and notification of results from four days to one day, according to a new study published in the January 31, 2006, online issue of Critical Care by Biomed Central (www.biomedcentral.com).

Stephan Harbarth and colleagues from the Geneva University Hospitals (Switzerland; www.hug-ge.ch) used quantitative MRSA (qMRSA), a new screening method that identifies MRSA DNA in patient swabs, to test 1,053 patients upon admission to the medical intensive care unit (ICU) and the surgical ICU in Geneva University Hospital. More...
The study ran from January 2003 to August 2005. Standard microbiologic methods were used to compare the time it took to get results of qMRSA with this method versus historical records of the time taken to get notification of test results.

The median time from ICU admission until notification of test results decreased from 87 hours to 21 hours in the surgical ICU and from 106 hours to 23 hours in the medical ICU. Infected patients immediately after MRSA detection substantially decreased MRSA infections in the medical ICU but not in the surgical ICU. In the surgical ICU, qMRSA spared 245 MRSA-negative patients a total of 1, 227 unnecessary days in isolation.




Related Links:
Geneva U. Hospitals

Gold Member
Neonatal Heel Incision Device
Tenderfoot
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Pediatric Mask
Respire SOFT
New
Breast Imaging Monitor
Barco Coronis Onelook MDMC-32133 32MP
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image Credit: Adobe Stock

New ECG Foundation Model Enables Broad Cardiac Diagnosis and Risk Prediction

Electrocardiograms are central to cardiovascular decision-making, but conventional artificial intelligence models are often trained for narrow tasks, such as detecting a single arrhythmia.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.